{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:26Z","timestamp":1761058766815,"version":"3.40.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1007\/bf02752256","type":"journal-article","created":{"date-parts":[[2007,12,19]],"date-time":"2007-12-19T05:31:52Z","timestamp":1198042312000},"page":"123-134","source":"Crossref","is-referenced-by-count":16,"title":["Overview of vaccines"],"prefix":"10.1007","volume":"8","author":[{"given":"Gordon","family":"Ada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02752256_CR1","volume-title":"Vaccines, Vaccinations and the Immune Response","author":"G. Ada","year":"1977","unstructured":"Ada, G. and Ramsay, A. (1977)Vaccines, Vaccinations and the Immune Response. Lippincott-Raven, Philadelphia, PA."},{"key":"BF02752256_CR2","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/0140-6736(92)92027-D","volume":"339","author":"M. Cadoz","year":"1992","unstructured":"Cadoz, M., Strady, A., Meigner, B., Taylor, J., Tartaglia, J., Paoletti, E., and Plotkin, S. (1992) Immunization with canarypox virus expressing rabies glycoprotein.Lancet\n                           339, 1429\u20131432.","journal-title":"Lancet"},{"key":"BF02752256_CR3","first-page":"809","volume-title":"Vaccines","author":"H. F. Clark","year":"1994","unstructured":"Clark, H. F. and Offit, P. A. (1994) Rotavirus vaccines, inVaccines (2nd ed.) (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, PA. pp. 809\u2013822.","edition":"2nd ed."},{"key":"BF02752256_CR4","first-page":"781","volume-title":"Vaccines","author":"H. F. Maassab","year":"1994","unstructured":"Maassab, H. F., Shaw, M. W., and Heilman, C. A. (1994) Live influenza virus vaccines, inVaccines (2nd ed.) (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, PA, pp. 781\u2013801.","edition":"2nd ed."},{"key":"BF02752256_CR5","first-page":"597","volume-title":"Vaccines","author":"M. M. Levine","year":"1994","unstructured":"Levine, M. M. (1994) Typhoid fever vaccines, inVaccines (2nd ed.) (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, PA, pp. 597\u2013634.","edition":"2nd ed."},{"key":"BF02752256_CR6","first-page":"23","volume":"82","author":"R. Curtiss","year":"1994","unstructured":"Curtiss, R., III, Kelly, S. M., Tinge, S. A., Tackett, C. O., Levine, M. M., Srinivasan, J., and Koopman, M. (1994) Recombinant Salmonella vectors in vaccine development.Dev. Biol. Stand.\n                           82, 23\u201333.","journal-title":"Dev. Biol. Stand."},{"key":"BF02752256_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","volume":"188","author":"J. Tartaglia","year":"1992","unstructured":"Tartaglia, J., Perkus, M. E., and Taylor, J. (1992) NYVAC: a highly attenuated strain of vaccinia virus.Virology\n                           188, 217\u2013232.","journal-title":"Virology"},{"key":"BF02752256_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1126\/science.1470917","volume":"258","author":"M. D. Daniel","year":"1992","unstructured":"Daniel, M. D., Kirchoff, F., Czajak, S. C., Seghel, O. K., and Desrosiers, R. C. (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.Science\n                           258, 1938\u20131940.","journal-title":"Science"},{"key":"BF02752256_CR9","first-page":"91","volume-title":"Pertussis vaccine","author":"E. A. Mortimer","year":"1994","unstructured":"Mortimer, E. A. (1994) Pertussis vaccine, inVaccines (2nd ed.) (Plotkin, S. A. and Mortimer, E. A., eds.), Saunders, Philadelphia, PA, pp 91\u2013136.","edition":"2nd ed."},{"key":"BF02752256_CR10","first-page":"1649","volume":"216B","author":"J. Holmgren","year":"1987","unstructured":"Holmgren, J., Svennerholm, A. M., Clemens, J. D., Sack, D., Black, R., and Levine, M. (1987) An oral B subunit against cholera: from concept to successful field trial.Adv. Exp. Med. Biol.\n                           216B, 1649\u20131660.","journal-title":"Adv. Exp. Med. Biol."},{"key":"BF02752256_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/icb.1988.19","volume":"66","author":"A. Mullbacher","year":"1988","unstructured":"Mullbacher, A., Ada, G. L., and Tha Hla, R. (1988) Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A virus.Immunol. Cell Biol.\n                           66, 153\u2013158.","journal-title":"Immunol. Cell Biol."},{"key":"BF02752256_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1084\/jem.147.4.1236","volume":"147","author":"T. J. Braciale","year":"1978","unstructured":"Braciale, T. J. and Yap, K. L. (1978) Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells.J. Exp. Med.\n                           147, 1236\u20131252.","journal-title":"J. Exp. Med."},{"key":"BF02752256_CR13","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.4049\/jimmunol.157.8.3658","volume":"157","author":"J. N. Flynn","year":"1996","unstructured":"Flynn, J. N., Keating, P., Hosie, M. J., Mackett, M., Stephens, E. B., Beatty, J. A., Neil, J. C., and Jarrett, O. (1996) Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.J. Immunol.\n                           157, 3658\u20133665.","journal-title":"J. Immunol."},{"key":"BF02752256_CR14","first-page":"1","volume":"1","author":"M. R. Hilleman","year":"1992","unstructured":"Hilleman, M. R. (1992) Vaccine perspectives from the vantage of hepatitis B.Vaccine Res.1, 1\u201315.","journal-title":"Vaccine Res"},{"key":"BF02752256_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1084\/jem.173.3.531","volume":"173","author":"E. Egea","year":"1991","unstructured":"Egea, E., Iglesias, A., Salazar, M., Morimoto, C., Kruskall, M. S., Awdeh, Z., Schlossman, F. S., Alper, C. A., and Yunis, E. J. (1991) The cellular basis for lack of antibody response to hepatitis B vaccine in humans.J. Exp. Med.\n                           173, 531\u2013542.","journal-title":"J. Exp. Med."},{"key":"BF02752256_CR16","first-page":"841","volume":"119","author":"I. D. Langmuir","year":"1984","unstructured":"Langmuir, I. D., Bregman, D. J., Kurlland, L. D., Nathanson, N., and Vector, M. (1984) An epidemiological and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccine.J. Epidemiol.\n                           119, 841\u2013879.","journal-title":"J. Epidemiol."},{"key":"BF02752256_CR17","first-page":"1","volume-title":"Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality","author":"K. R. Stratton","year":"1994","unstructured":"Stratton, K. R., Howe, C. J., and Johnston, R. B. (1994)Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Institute of Medicine, National Academy Press, Washington, DC, pp. 1\u2013464."},{"key":"BF02752256_CR18","first-page":"357","volume":"62","author":"A. M. Galaska","year":"1984","unstructured":"Galaska, A. M., Lauer, B. A., Henderson, R. H., and Keja, J. (1984) Indications and contra-indications for vaccines used in the Expanded Programme of Immunization.Bull. WHO\n                           62, 357\u2013366.","journal-title":"Bull. WHO"},{"key":"BF02752256_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00006454-199306000-00002","volume":"12","author":"N. A. Halsey","year":"1993","unstructured":"Halsey, N. A. (1993) Increased mortality following high titer measles vaccines: too much of a good thing.Pediat. Infect. Dis.\n                           12, 462\u2013465.","journal-title":"Pediat. Infect. Dis."},{"key":"BF02752256_CR20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","volume":"89","author":"A. Z. Kapikian","year":"1969","unstructured":"Kapikian, A. Z., Mitchell, R. H., and Chanock, R. M. (1969) An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus in children previously vaccinated with inactivated RS virus vaccine.Am. J. Epidemiol.\n                           89, 405\u2013421.","journal-title":"Am. J. Epidemiol."},{"key":"BF02752256_CR21","first-page":"293","volume":"69","author":"Expanded Programme of Immunization","year":"1994","unstructured":"Expanded Programme of Immunization. Certification of poliomyelitis eradication: the Americas, 1994. (1994)Wk. Epidemiol. Rec.\n                           69, 293\u2013295.","journal-title":"Wk. Epidemiol. Rec."},{"key":"BF02752256_CR22","first-page":"187","volume-title":"New Approaches for Vaccine Development","author":"F. Fenner","year":"1984","unstructured":"Fenner, F. (1984) Viral vectors for vaccines, inNew Approaches for Vaccine Development (Bell, R. and Torrigiani, G., eds.), Schwabe, Basel, pp. 187\u2013192."},{"key":"BF02752256_CR23","unstructured":"WHO Consultative Group on Poliomyelitis Vaccines. (1984) Report to World Health Organization, Geneva."},{"key":"BF02752256_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/0952-7915(93)90121-8","volume":"5","author":"G. Ada","year":"1993","unstructured":"Ada, G. (1993) Vaccination in third world countries: guest editorial.Curr. Opin. Immunol.\n                           5, 683\u2013686.","journal-title":"Curr. Opin. Immunol."},{"key":"BF02752256_CR25","unstructured":"Measles Elimination by the Year 2000! (1994) EPI Newsletter (vol. 16); Pan American Health Organization, Washington, DC."},{"key":"BF02752256_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/infdis\/168.2.269","volume":"168","author":"R. G. Douglas","year":"1993","unstructured":"Douglas, R. G. (1993) The Childlren\u2019s Vaccine Initiative: will it work?J. Inf. Dis.\n                           168, 269\u2013274.","journal-title":"J. Inf. Dis."},{"key":"BF02752256_CR27","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","volume":"85","author":"J. P. Tam","year":"1988","unstructured":"Tam, J. P. (1988) Synthetic peptide vaccine design: synthesis and properties of a high density multiple antigenic peptide system.Proc. Natl. Acad. Sci. USA\n                           85, 5409\u20135413.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02752256_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","volume":"344","author":"S. Pruksakorn","year":"1994","unstructured":"Pruksakorn, S., Currie, B., Brandt, E., Martin, D., Galbraith, A., Phornphutkin, C., Hunsakunachai, S., Manmontri, A., and Good, M. F. (1994) Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.Lancet\n                           344, 639\u2013642.","journal-title":"Lancet"},{"key":"BF02752256_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/bi00453a002","volume":"29","author":"P. T. P. Kaumaya","year":"1990","unstructured":"Kaumaya, P. T. P., Berndt, K. D., Heidorn, D. B., Trewhella, J., Kezdy, F. J., and Goldberg, E. (1990) Synthesis and biochemical characterization of engineered topographic immunogenic determinants with topology.Biochemistry\n                           29, 13\u201323.","journal-title":"Biochemistry"},{"key":"BF02752256_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1126\/science.8160012","volume":"264","author":"A. J. Ramsay","year":"1994","unstructured":"Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Matthaei, K. I., Kochler, G., and Kopf, M. (1994) The role of interleukin 6 in mucosal IgA antibody responses in vivo.Science\n                           264, 561\u2013563.","journal-title":"Science"},{"key":"BF02752256_CR31","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/0264-410X(94)90069-8","volume":"12","author":"F. Schoedel","year":"1994","unstructured":"Schoedel, F., Aguado, M.-T., and Lambert, P.-H. (1994) Introduction. Nucleic acid vaccines, plus many other contributions.Vaccine\n                           12, 1491\u20131550.","journal-title":"Vaccine"},{"key":"BF02752256_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nm0597-526","volume":"3","author":"J. D. Boyer","year":"1997","unstructured":"Boyer, J. D., Ugen, K. E., and Wang, B. (1997) Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination.Nature Med.\n                           3, 526\u2013531.","journal-title":"Nature Med."},{"key":"BF02752256_CR33","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.4049\/jimmunol.158.6.2513","volume":"158","author":"W. C. Lai","year":"1997","unstructured":"Lai, W. C., Pakes, S. P., Ren, K., Lu, Y.-S., and Bennett, M. (1997) Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis.J. Immunol.\n                           158, 2513\u20132516.","journal-title":"J. Immunol."},{"key":"BF02752256_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0008-8749(82)90223-4","volume":"67","author":"K.-N. Leung","year":"1982","unstructured":"Leung, K.-N. and Ada, G. L. (1982) Different functions of subsets of effector T cells in murine influenza virus infection.Cell Immunol.\n                           67, 312\u2013324.","journal-title":"Cell Immunol."},{"key":"BF02752256_CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/iai.41.1.197-204.1983","volume":"41","author":"H. S. Larson","year":"1983","unstructured":"Larson, H. S., Russell, R. G., and Rouse, B. Y. (1983) Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.Infect. Immunol.\n                           41, 197\u2013204.","journal-title":"Infect. Immunol."},{"key":"BF02752256_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/icb.1976.35","volume":"54","author":"D. C. Jackson","year":"1976","unstructured":"Jackson, D. C., Ada, G. L., and Tha Hla, R. (1976) Cytotoxic T cells recognize very early, minor changes in ectromelia virus-infected target cells.Aust. J. Exp. Biol. Med. Sci.\n                           54, 349\u2013363.","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"BF02752256_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1084\/jem.145.3.644","volume":"145","author":"R. M. Zinkernagel","year":"1977","unstructured":"Zinkernagel, R. M. and Althage, A. (1977) Anti-viral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled.J. Exp. Med.\n                           145, 644\u2013651.","journal-title":"J. Exp. Med."},{"key":"BF02752256_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0167-7799(91)90137-7","volume":"9","author":"M. J. Geisow","year":"1991","unstructured":"Geisow, M. J. (1991) Unravelling the mysteries of molecular audit: MHC class I restriction.Tibtech\n                           9, 403,404.","journal-title":"Tibtech"},{"key":"BF02752256_CR39","first-page":"243","volume":"13","author":"G. L. Ada","year":"1996","unstructured":"Ada, G. L. and McElrath, M. J. (1996) Perspective. HIV-1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy.AIDS Res. Hum. Retrov.\n                           13, 243\u2013248.","journal-title":"AIDS Res. Hum. Retrov."},{"key":"BF02752256_CR40","first-page":"17","volume-title":"Strategies in Vaccine Design","author":"G. Taylor","year":"1994","unstructured":"Taylor, G. (1994) The role of antibody in controlling and\/or clearing virus infections, inStrategies in Vaccine Design (Ada, G. L., ed.) R G Landes, Austin, TX, pp. 17\u201334."},{"key":"BF02752256_CR41","first-page":"111","volume":"4","author":"D. E. Griffin","year":"1992","unstructured":"Griffin, D. E., Levine, B., Tyor, W. B., and Irani, D. N. (1992) The immune response in viral encephalitis.Semin. Immunol.\n                           4, 111\u2013119.","journal-title":"Semin. Immunol."},{"key":"BF02752256_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.174.4.875","volume":"174","author":"M. Eichelberger","year":"1991","unstructured":"Eichelberger, M., Allan, W., Zijlstra, M., Jaenisch, R., and Doherty, P. C. (1991) Clearance of influenza virus respiratory infection in mice lacking class i major histocompatibility complex-restricted CD8+T cells.J. Exp. Med.\n                           174, 875\u2013880.","journal-title":"J. Exp. Med."},{"key":"BF02752256_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-065X.1992.tb01413.x","volume":"127","author":"I. A. Ramshaw","year":"1992","unstructured":"Ramshaw, I. A., Ruby, J., Ramsay, A. J., Ada, G., and Karupiah, G. (1992) Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo.Immunol. Rev.\n                           127, 157\u2013182.","journal-title":"Immunol. Rev."},{"key":"BF02752256_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0140-6736(90)90748-T","volume":"335","author":"G. L. Ada","year":"1990","unstructured":"Ada, G. L. (1990) The immune response to antigens: the immunological principles of vaccination.Lancet\n                           335, 523\u2013526.","journal-title":"Lancet"},{"key":"BF02752256_CR45","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/jvi.70.10.7103-7107.1996","volume":"70","author":"D. P. Sharma","year":"1996","unstructured":"Sharma, D. P., Ramsay, A. J., Maguire, D. J., Rolph, M. S., and Ramshaw, I. A. (1996) Interleukin-4 mediates down regulation of antiviral cytokine expression and of cytotoxic T lymphocyte responses, and exacerbates vaccinia virus expression in vivo.J. Virol.\n                           70, 7103\u20137107.","journal-title":"J. Virol."},{"key":"BF02752256_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1126\/science.7904381","volume":"263","author":"L. C. C. Alfonso","year":"1994","unstructured":"Alfonso, L. C. C., Scharton, T. M., Vieira, J. Q., Wysocka, M., Trinchieri, G., and Scott, P. (1994) The adjuvant effect of interleukin-12 in a vaccine againtsLeishmania major.Science\n                           263, 235\u2013237.","journal-title":"Science"},{"key":"BF02752256_CR47","doi-asserted-by":"crossref","first-page":"10,795","DOI":"10.1073\/pnas.91.23.10795","volume":"91","author":"J. B. Sun","year":"1994","unstructured":"Sun, J. B., Holmgren, J., and Czerkinsky, C. (1994) Cholera toxin B subunit: an efficient trans-mucosal delivery system for induction of peripheral tolerance.Proc. Natl. Acad. Sci. USA\n                           91, 10,795\u201310,799.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02752256_CR48","first-page":"129","volume-title":"Strategies in Vaccine Design","author":"P. D. Cooper","year":"1994","unstructured":"Cooper, P. D. (1994) The selective induction of different immune responses by vaccine adjuvants, inStrategies in Vaccine Design (Ada, G. L., ed.), R G Landes, Austin, TX, pp. 129\u2013158."},{"key":"BF02752256_CR49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/167.3.533","volume":"167","author":"B. S. Graham","year":"1993","unstructured":"Graham, B. S., Matthews, T. J., Belshe, R. B., Clements, M. L., Dolin, R., Wright, P. F., Gorse, G. G., and Schwartz, D. H. (1993) Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia naive adults.J. Inf. Dis.\n                           167, 533\u2013537.","journal-title":"J. Inf. Dis."},{"key":"BF02752256_CR50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/infdis\/168.2.306","volume":"168","author":"N. El-Daher","year":"1993","unstructured":"El-Daher, N., Keefer, M. C., Reichnnan, R. C., Dolin, R., and Roberts, N. S. (1993) Persisting immunodeficiency virus type 1 gp 160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines.J. Inf. Dis.\n                           168, 306\u2013313.","journal-title":"J. Inf. Dis."},{"key":"BF02752256_CR51","first-page":"321","volume-title":"Vaccines, \u203295","author":"K. H. Leong","year":"1995","unstructured":"Leong, K. H., Ramsay, A. J., Moein, M. J., Ramshaw, I. A., and Ruby, J. (1995) Generation of enhanced immune responses by consecutive immunization with DNA and recombinant fowlpox virus, inVaccines, \u203295 (Brown, F., Chanock, R., Ginsberg, H., Norrby, E., eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 321\u2013327."},{"key":"BF02752256_CR52","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4049\/jimmunol.144.4.1177","volume":"144","author":"A. M. Gautam","year":"1990","unstructured":"Gautam, A. M. and Glynn, P. (1990) Competition between foreign and self proteins in antigen presentation: ovalbumin can inhibit activation of myelin basic protein-specific T cells.J. Immunol.\n                           144, 1177\u20131180.","journal-title":"J. Immunol."}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02752256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02752256\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02752256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02752256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:31:21Z","timestamp":1744147881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02752256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["BF02752256"],"URL":"https:\/\/doi.org\/10.1007\/bf02752256","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}